In a groundbreaking development in the pharmaceutical industry, Danish drugmaker Novo Nordisk has entered into a strategic partnership with Valo Health, a US-based startup renowned for its cutting-edge capabilities in AI drug discovery. Novo Nordisk’s investment of $60 million signifies a significant step forward in the quest to find innovative therapies for cardiometabolic diseases. This ... Read more
